ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

KZR Kezar Life Sciences Inc

0.8245
-0.0133 (-1.59%)
After Hours
Last Updated: 15:56:59
Delayed by 15 minutes

Period:

Draw Mode:

Volume 633,983
Bid Price 0.8003
Ask Price 0.8449
News -
Day High 0.85

Low
0.6746

52 Week Range

High
3.13

Day Low 0.82
Share Name Share Symbol Market Stock Type
Kezar Life Sciences Inc KZR NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.0133 -1.59% 0.8245 15:56:59
Open Price Low Price High Price Close Price Previous Close
0.8378 0.82 0.85 0.8245 0.8378
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
4,575 633,983 US$ 0.8315306 US$ 527,176 - 0.6746 - 3.13
Last Trade Type Quantity Price Currency
15:20:10 16 US$ 0.8245 USD

Kezar Life Sciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
59.7M 72.80M - 7M -101.87M -1.40 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Kezar Life Sciences News

Date Time Source News Article
4/08/202415:01Business WireKezar Announces Inducement Grant Under NASDAQ Listing Rule..
3/14/202415:01Business WireKezar Life Sciences Reports Fourth Quarter and Year End 2023..
3/08/202415:05Business WireKezar Announces Inducement Grant Under NASDAQ Listing Rule..
2/28/202415:01Business WireKezar Life Sciences to Participate in the TD Cowen 44th..
2/26/202417:30Business WireEverest Medicines and Kezar Life Sciences Receive IND..
2/14/202405:50Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial..
1/17/202416:09Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of..
1/09/202415:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
1/08/202407:36Edgar (US Regulatory)Form 8-K - Current report
12/04/202315:28Edgar (US Regulatory)Form 8-K - Current report
11/21/202315:01Business WireKezar Life Sciences to Present at the 6th Annual Evercore..
11/13/202315:13Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No KZR Message Board. Create One! See More Posts on KZR Message Board See More Message Board Posts

Historical KZR Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.8110.850.7730.8127383522,8590.01351.66%
1 Month0.8680.8970.75020.821213646,226-0.0435-5.01%
3 Months0.94511.1350.75020.9035137790,374-0.1206-12.76%
6 Months0.751.1350.67460.8820067705,8820.07459.93%
1 Year2.353.130.67461.44672,477-1.53-64.91%
3 Years5.6318.550.67466.97861,907-4.81-85.36%
5 Years19.7821.600.67466.75622,129-18.96-95.83%

Kezar Life Sciences Description

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as KZR-616, and the protein secretion program.

Your Recent History

Delayed Upgrade Clock